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AT A GLANCE
Population: 19,193,382
Per capita income: $1,810 
Life expectancy at birth: F 61/M 60 years
Infant mortality rate: 57/1,000 live births
TOP 10 CAUSES OF DEATH
1.    Malaria
2.    Lower respiratory infections
3.    Neonatal disorders
4.    Diarrheal diseases
5.    lschemic heart disease
6.    Tuberculosis
7.    Congenital defects
8.    Stroke




2     U.S. Assignees
3     Locally Employed
Global Health Security 
In today’s globally connected world, disease threats can spread faster than ever 
before. CDC’s global health security efforts in Burkina Faso help improve its ability 
to prevent, detect, and respond to infectious disease outbreaks before they 
become epidemics that could affect global populations. These efforts help Burkina 
Faso reach the targets outlined in the Global Health Security Agenda (GHSA), 
a global partnership launched in 2014 to help make the world safer and more 
secure from infectious disease threats. CDC collaborates with Burkina Faso to build 
core public health capacities in disease surveillance, laboratory systems, workforce 
development, and emergency management. 
Emergency Operations 
Burkina Faso has made immense progress in increasing rapid response and 
public health emergency management capacity. In December 2018, Burkina Faso 
officially inaugurated its Public Health Emergency Operations Center (Centre des 
Opérations de Réponse aux Urgences Sanitaires, CORUS). The inauguration marks 
a significant milestone for Burkina Faso's efforts to achieve commitments made 
under the International Health Regulations. 
Antimicrobial Resistance 
With CDC support, Burkina Faso took critical steps to implement antimicrobial 
resistance surveillance in 14 laboratories at national and subnational levels 
including the national laboratory for animal health. Thirteen priority bacterial 
pathogens have been selected by the country to be monitored. 
The Centers for Disease Control and Prevention (CDC) first began collaborating with the Ministry of Health of Burkina Faso 
in 1991. The initial technical support for polio eradication expanded to include other vaccine preventable diseases such 
as measles and meningitis.  With the launch of the Global Health Security Agenda, CDC established an office in Burkina 
Faso in 2016 focused on strengthening the country’s ability to prevent, detect, and respond to public health threats, 
and to strengthen the country's capacity in surveillance, laboratory systems, workforce development, and emergency 
management.
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Field Epidemiology and Laboratory Training 
Program
CDC supports Burkina Faso in strengthening the capacity of its workforce to
investigate and respond to disease outbreaks through the establishment of a
Field Epidemiology and Laboratory Training Program (FELTP). Fellows learn  to 
identify and contain outbreaks before they become epidemics. Training focuses 
on "learning by doing" to develop the skills for gathering critical data and 
turning it into evidence-based action.
CDC collaborated with the World Bank and the University of Ouagadougou 
to host the regional West Africa Field Epidemiology and Laboratory Training 
Program for the eight French-speaking countries of West Africa (Benin, Burkina 
Faso, Côte d’Ivoire, Guinea, Mali, Niger, Senegal, and Togo.) This two-year 
training has been adapted to a three-month frontline level. In Burkina Faso, 138 
Frontline fellows have graduated the FELTP program as of October 2018.
Arbovirus Sentinel Surveillance
During the 2017 dengue outbreak in Burkina Faso, CDC supported the MOH 
to establish laboratory-based arbovirus sentinel surveillance at two sites in 
the capital city of Ouagadougou. The new system is used to improve existing 
routine surveillance through revised case reporting forms, systematic testing 
of specimens, and linking patient information with laboratory results through 
a data management system. After successful implementation at the sentinel 
sites, the MOH will add five additional sentinel sites. 
Burkina Faso's National Arbovirus Viral Hemorrhagic Fever Reference 
Laboratory achieved capacity to test for Lassa fever, Crimean Congo
hemorrhagic fever, Rift Valley fever, dengue, chikungunya, and Zika viruses 
enabling accurate identification and faster containment of infectious
disease threats across the country.
Specimen Referral System
Burkina Faso Ministry of Health (MOH) along with CDC and partners, 
successfully designed and piloted a reliable and cost effective specimen referral 
system which will be expanded over time to be a multi-pathogen, integrated 
system. The initial pilot referral system connects four district laboratories to 
the National Influenza Reference Laboratory (LNR-G) via SONAPOST (National 
Post System), using their express mail service. Key improvements noted by the 
monitoring system following the introduction of the pilot included: delivery 
of samples within 24 hours; training to ensure specimen quality and biosafety, 
cost-containment using volume based pricing, and improved data collection 
and tracking.
Event-Based Surveillance
In sub-Saharan Africa, emerging pathologies and epidemic-prone diseases 
require strengthening of surveillance systems. Burkina RESPIRE, implemented 
by the MOH, CDC and Davycas International, aims to complement indicator-
based surveillance through introduction of event-based surveillance (EBS) in 
communities. The MOH identified 10 health signals that map to syndromes 
and diseases recommended for immediate notification according to Integrated 
Disease Surveillance and Response guidelines. Training materials and 
notification procedures were developed and a cascade-training program for 
community health workers was implemented in 2017.
CDC IMPACT IN
BURKINA FASO
17 million doses of polio vaccine and 2.4 
million doses of measles vaccine were given 
to children under five years of age. 
More than 12 million people have been 
vaccinated against meningitis.
Public health workers from ten national and 
regional laboratories handling dangerous 
pathogens have been trained on enhanced 
biosafety practices. 
The CORUS (Public Health Emergency 
Operation Center) was officially inaugurated 
in 2018. 
Burkina Faso can now test for 10  priority 
pathogens (influenza, HIV, Mycobacterium 
tuberculosis, Plasmodium species, 
Salmonella Typhi, Vibrio cholerae, dengue, 
yellow fever, measles, N. meningitis). 
National diagnostic capacity in human 
and animal health laboratories has been 
enhanced to include detection capacity for 
at least 40 pathogens.  
For more country information, visit: 
www.cdc.gov/globalhealth/countries/burkinafaso
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